{"filing":{"accession_number":"0001185185-26-004190","cik":"0002088103","ticker":"XFLH-UN","company_name":"XFLH Capital Corp","form":"8-K","filing_date":"2026-09-22","report_date":"2026-09-18","primary_document":"xflh8k021326.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/2088103/000118518526004190/xflh8k021326.htm"},"events":[{"id":34209,"run_id":31477,"accession_number":"0001185185-26-004190","anchor_item_number":"1.01","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.95,"summary":"XFLH Capital Corporation, a SPAC, entered into a non-binding letter of intent with Renogen Biolab Inc. on September 18, 2026 for a proposed business combination involving a health service provider with molecular capabilities. The parties have committed to negotiate definitive agreements in good faith.","company_name":"XFLH Capital Corp","ticker":"XFLH-UN","filing_date":"2026-09-22","form":"8-K","submitted_at":null,"items":[{"id":37882,"accession_number":"0001185185-26-004190","item_number":"1.01","item_title":"Entry into a Material Definitive","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.95,"reasoning":"XFLH Capital Corporation, a SPAC, entered into a non-binding letter of intent with Renogen Biolab Inc. for a proposed business combination on September 18, 2026. The filing discloses entry into a material definitive agreement (Item 1.01) regarding a business combination involving a health service provider with molecular capabilities. This is a core M\u0026A activity that would materially affect investors' assessment of the registrant's strategic direction and future operations.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-22T12:31:50.323876+00:00","company_name":"","ticker":null,"filing_date":""},{"id":37883,"accession_number":"0001185185-26-004190","item_number":"8.01","item_title":"Other Events.","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the signing of a non-binding Letter of Intent for a proposed business combination between XFLH Capital Corporation (a SPAC) and Renogen Biolab Inc. The parties have committed to negotiate definitive agreements in good faith. This represents entry into a material acquisition/merger transaction, which is a core M\u0026A activity event that would materially affect a reasonable investor's assessment of the registrant's future direction and value.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-22T12:31:50.323876+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":37882,"accession_number":"0001185185-26-004190","item_number":"1.01","item_title":"Entry into a Material Definitive","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.95,"reasoning":"XFLH Capital Corporation, a SPAC, entered into a non-binding letter of intent with Renogen Biolab Inc. for a proposed business combination on September 18, 2026. The filing discloses entry into a material definitive agreement (Item 1.01) regarding a business combination involving a health service provider with molecular capabilities. This is a core M\u0026A activity that would materially affect investors' assessment of the registrant's strategic direction and future operations.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-22T12:31:50.323876+00:00","company_name":"XFLH Capital Corp","ticker":"XFLH-UN","filing_date":"2026-09-22"},{"id":37883,"accession_number":"0001185185-26-004190","item_number":"8.01","item_title":"Other Events.","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the signing of a non-binding Letter of Intent for a proposed business combination between XFLH Capital Corporation (a SPAC) and Renogen Biolab Inc. The parties have committed to negotiate definitive agreements in good faith. This represents entry into a material acquisition/merger transaction, which is a core M\u0026A activity event that would materially affect a reasonable investor's assessment of the registrant's future direction and value.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-22T12:31:50.323876+00:00","company_name":"XFLH Capital Corp","ticker":"XFLH-UN","filing_date":"2026-09-22"}]}